163 related articles for article (PubMed ID: 6847780)
1. Multiple estrogen receptor assays in human breast cancer.
Hull DF; Clark GM; Osborne CK; Chamness GC; Knight WA; McGuire WL
Cancer Res; 1983 Jan; 43(1):413-6. PubMed ID: 6847780
[TBL] [Abstract][Full Text] [Related]
2. Multiple progesterone receptor assays in human breast cancer.
Gross GE; Clark GM; Chamness GC; McGuire WL
Cancer Res; 1984 Feb; 44(2):836-40. PubMed ID: 6692382
[TBL] [Abstract][Full Text] [Related]
3. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
4. Effect of operative devascularization on estrogen and progesterone receptor levels in breast cancer specimens.
Teicher I; Tinker MA; Auguste LJ; Laufer H; Stein TA; Wise L
Surgery; 1985 Oct; 98(4):784-91. PubMed ID: 4049250
[TBL] [Abstract][Full Text] [Related]
5. HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.
Elledge RM; Green S; Ciocca D; Pugh R; Allred DC; Clark GM; Hill J; Ravdin P; O'Sullivan J; Martino S; Osborne CK
Clin Cancer Res; 1998 Jan; 4(1):7-12. PubMed ID: 9516946
[TBL] [Abstract][Full Text] [Related]
6. Enzyme immunoassay of estrogen receptors in fine needle aspirates of breast tumors.
Magdelenat H; Merle S; Zajdela A
Cancer Res; 1986 Aug; 46(8 Suppl):4265s-4267s. PubMed ID: 3524807
[TBL] [Abstract][Full Text] [Related]
7. Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.
McClelland RA; Finlay P; Walker KJ; Nicholson D; Robertson JF; Blamey RW; Nicholson RI
Cancer Res; 1990 Jun; 50(12):3545-50. PubMed ID: 2187598
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
; Colleoni M; Gelber S; Goldhirsch A; Aebi S; Castiglione-Gertsch M; Price KN; Coates AS; Gelber RD
J Clin Oncol; 2006 Mar; 24(9):1332-41. PubMed ID: 16505417
[TBL] [Abstract][Full Text] [Related]
10. Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.
Broom RJ; Tang PA; Simmons C; Bordeleau L; Mulligan AM; O'Malley FP; Miller N; Andrulis IL; Brenner DM; Clemons MJ
Anticancer Res; 2009 May; 29(5):1557-62. PubMed ID: 19443366
[TBL] [Abstract][Full Text] [Related]
11. Sex steroid receptor concentration in breast carcinoma tissue: effect of devascularization during mastectomy.
Leight GS; Wells SA; McCarty KS
Surgery; 1984 Mar; 95(3):256-60. PubMed ID: 6701781
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers.
Nicholson RI; Colin P; Francis AB; Keshra R; Finlay P; Williams M; Elston CW; Blamey RW; Griffiths K
Cancer Res; 1986 Aug; 46(8 Suppl):4299s-4302s. PubMed ID: 3524811
[TBL] [Abstract][Full Text] [Related]
13. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
[TBL] [Abstract][Full Text] [Related]
14. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor status in breast cancer.
Wright CJ
Can J Surg; 1980 Jul; 23(4):316-7. PubMed ID: 7417890
[TBL] [Abstract][Full Text] [Related]
16. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer.
Mann GB; Fahey VD; Feleppa F; Buchanan MR
J Clin Oncol; 2005 Aug; 23(22):5148-54. PubMed ID: 16051956
[TBL] [Abstract][Full Text] [Related]
17. Impact of metastatic estrogen receptor and progesterone receptor status on survival.
Lower EE; Glass EL; Bradley DA; Blau R; Heffelfinger S
Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.
Arpino G; Weiss HL; Clark GM; Hilsenbeck SG; Osborne CK
J Clin Oncol; 2005 Jul; 23(21):4687-94. PubMed ID: 15837971
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.
Reiner A; Spona J; Reiner G; Schemper M; Kolb R; Kwasny W; Függer R; Jakesz R; Holzner JH
Am J Pathol; 1986 Dec; 125(3):443-9. PubMed ID: 3541638
[TBL] [Abstract][Full Text] [Related]
20. Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.
Khoshnoud MR; Fornander T; Johansson H; Rutqvist LE
Breast Cancer Res Treat; 2008 Jan; 107(1):71-8. PubMed ID: 18043896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
